These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38750479)

  • 1. The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial.
    Yan N; Hu S
    BMC Psychiatry; 2024 May; 24(1):365. PubMed ID: 38750479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
    Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
    J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive Symptoms in Stroke Patients: Are There Sex Differences?
    Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S
    Cerebrovasc Dis; 2020; 49(1):19-25. PubMed ID: 32023608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of nine antidepressants in treating Chinese patients with post-stroke depression: A network meta-analysis.
    Li X; Zhang C
    J Affect Disord; 2020 Apr; 266():540-548. PubMed ID: 32056924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A target trial emulation comparing the antidepressant effectiveness of selective serotonin reuptake inhibitors (SSRIs) highlighting the importance of patent-related confounding by indication.
    Rohde C; Hieronymus F; Østergaard SD
    Acta Psychiatr Scand; 2024 Oct; 150(4):198-208. PubMed ID: 38994727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
    Stahl SM
    Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
    Lyketsos CG; DelCampo L; Steinberg M; Miles Q; Steele CD; Munro C; Baker AS; Sheppard JM; Frangakis C; Brandt J; Rabins PV
    Arch Gen Psychiatry; 2003 Jul; 60(7):737-46. PubMed ID: 12860778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L
    J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
    Kilts CD; Wade AG; Andersen HF; Schlaepfer TE
    Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing depression after stroke: Results from a randomized placebo-controlled trial.
    Almeida OP; Waterreus A; Hankey GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1104-9. PubMed ID: 16889454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
    Davidson JR; Bose A; Korotzer A; Zheng H
    Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of adding celecoxib to escitalopram for improving symptoms of major depressive disorder.
    Nadi Sakhvidi M; Salami Z; Mosadegh M; Bidaki R; Fallahzadeh H; Salehabadi R; Arjmandi M
    Int J Psychiatry Med; 2024 Sep; 59(5):511-520. PubMed ID: 38116669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
    Rocca P; Calvarese P; Faggiano F; Marchiaro L; Mathis F; Rivoira E; Taricco B; Bogetto F
    J Clin Psychiatry; 2005 Mar; 66(3):360-9. PubMed ID: 15766303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
    J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study.
    Huang M; Luo B; Hu J; Wei N; Chen L; Wang S; Zhou W; Hu S; Xu Y
    Int Clin Psychopharmacol; 2012 May; 27(3):151-8. PubMed ID: 22367417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
    Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
    Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.